Research And Development Expense in CHF of MOLECULAR PARTNERS AG from 2019 to 2024

Taxonomy & unit
ifrs-full: CHF
Summary
Molecular Partners Ag quarterly/annual Research And Development Expense history and change rate from 2019 to 2024.
  • Molecular Partners Ag Research And Development Expense for the quarter ending June 30, 2023 was ₣11.6M, a 7.47% decline year-over-year.
  • Molecular Partners Ag annual Research And Development Expense for 2024 was ₣48.6M, a 0.37% decline from 2023.
  • Molecular Partners Ag annual Research And Development Expense for 2023 was ₣48.8M, a 3.87% decline from 2022.
  • Molecular Partners Ag annual Research And Development Expense for 2022 was ₣50.7M, a 8.92% decline from 2021.
Research And Development Expense, Quarterly (CHF)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (CHF)
Research And Development Expense, YoY Annual Change (%)

MOLECULAR PARTNERS AG Quarterly Research And Development Expense (CHF)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 11.6M -939K -7.47% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-24
Q2 2022 12.6M Apr 1, 2022 Jun 30, 2022 6-K 2023-08-24

MOLECULAR PARTNERS AG Annual Research And Development Expense (CHF)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 48.6M -180K -0.37% Jan 1, 2024 Dec 31, 2024 20-F 2025-03-06
2023 48.8M -1.97M -3.87% Jan 1, 2023 Dec 31, 2023 20-F 2025-03-06
2022 50.7M -4.97M -8.92% Jan 1, 2022 Dec 31, 2022 20-F 2025-03-06
2021 55.7M -357K -0.64% Jan 1, 2021 Dec 31, 2021 20-F 2024-03-14
2020 56.1M +12.6M +28.9% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-09
2019 43.5M Jan 1, 2019 Dec 31, 2019 20-F 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.